[This patent] is assigned to The United States of America, as represented by the Department of Health and Human Services.
The patent claims that -
“Cannabinoids have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases. The cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease and HIV dementia.”
The patent was obtained in October of 2003.
“The cancer industry marginalizes safe and effective cures while promoting their patented, expensive, and toxic remedies whose risks far exceed any benefit. This is what they do best, and they do it because it makes money, plain and simple.” (More below video)